🔥 Premium AI-powered Stock Picks from InvestingPro Now up to 50% OffCLAIM SALE

Clinuvel Pharmaceuticals Ltd (CUV)

Sydney
Currency in AUD
Disclaimer
15.65
+0.59(+3.92%)
Closed
CUV Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Fair Value
Day's Range
15.0515.65
52 wk Range
12.9621.45
Bid/Ask
15.48 / 15.65
Prev. Close
15.06
Open
15.27
Day's Range
15.05-15.65
52 wk Range
12.96-21.45
Volume
62,661
Average Vol. (3m)
82,792
1-Year Change
-11.63%
Fair Value
Unlock
Fair Value Upside
Unlock
CUV Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
30.32
Upside
+93.74%
Members' Sentiments
Bearish
Bullish
ProTips
Impressive gross profit margins

People Also Watch

5.10
BAP
+3.66%
36.000
SVW
+0.78%
12.07
CDA
+0.58%
2.36
IFL
+3.06%
9.06
CKF
+1.12%

Clinuvel Pharmaceuticals Ltd Company Profile

Clinuvel Pharmaceuticals Limited, a biopharmaceutical company, focuses on developing and commercializing treatments for patients with genetic, metabolic, and life-threatening disorders in Australia, Europe, the United States, Switzerland, and internationally. Its lead drug candidate is SCENESSE, a systemic photoprotective drug for the prevention of phototoxicity in adult patients with erythropoietic protoporphyria (EPP). The company’s pipeline products include CUV9900, an alpha-melanocyte stimulating hormone analogue; Parvysmelanotide (VLRX001), which provoke prolonged cellular activity; and PRÉNUMBRA, a liquid injectable formulation of afamelanotide. The company was founded in 1987 and is headquartered in Melbourne, Australia.

Employees
0
Market
Australia
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.